Search alternatives:
points decrease » point decrease (Expand Search), point increase (Expand Search)
mean decrease » a decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
40 c » 4 c (Expand Search), 40 _ (Expand Search), 20 c (Expand Search)
points decrease » point decrease (Expand Search), point increase (Expand Search)
mean decrease » a decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
40 c » 4 c (Expand Search), 40 _ (Expand Search), 20 c (Expand Search)
-
1
-
2
-
3
Loss of C9orf72 decreases mTOR activation.
Published 2016“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
-
4
-
5
-
6
-
7
-
8
-
9
Decreased cell stiffness after dissociation of intercellular adhesion.
Published 2014“…In parallel, AFM-guided cell stiffness measurements were obtained by AFM nanomechanical measurement of 50 different cells under each of the conditions described above (<b>D</b>); Each bar represents the average and standard error of the mean (SEM) of repeated measurements for each condition. …”
-
10
-
11
-
12
-
13
-
14
<i>roh</i> mutation results in Rh1 decrease.
Published 2015“…<p>(A) GFP fluorescence of one-day old wild-type (left panel) and <i>roh</i><sup><i>EY04039</i></sup> (right panel) flies showing a reduction in Rh1-GFP. Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
-
15
-
16
-
17
-
18
-
19
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
20